Zoetis to acquire Nexvet Veterinary Biologic Therapeutics Co.April 13, 2017Zoetis Inc. announced it will purchase Nexvet Biopharma veterinary biologic therapeutics company for US $6.72 per share, or a valuation of approximately US $85 million. Pending approval, the purchase is expected to be completed during the second half of 2017.
SPONSORED CONTENTGive your patients FAST diarrhea reliefProbiotics or nutrition? Prioritize Hill's Prescription Diet GIB nutrition clinically shown to resolve diarrhea in as little as 24 hours. + Learn More
